Satoko Ogita

Evaluation of Virus Detection in Pediatric Patients Hospitalized with Respiratory Tract Infections Using Quantitative Multiplex PCR

Yuto Yasui, Tomohiro Oishi, Atsushi Kato, Satoko Ogita et autres

Respiratory tract infections (RTIs) are common in children. Viruses are known to be related to most pediatric infections. However, some pediatric cases of RTI have been found to be associated with multiple viruses. In this study, we collected samples from the nasopharynx …

Evaluation of Neutralizing Antibodies on Respiratory Syncytial Virus in Japanese Mother-Infant Pairs after COVID-19 Pandemic

Tomohiro Oishi, Daisuke Yoshioka, Sachie Ono, Yuto Yasui et autres

Respiratory syncytial virus (RSV) is the most common cause of acute lower respiratory tract infection in young children globally. Following the COVID-19 pandemic, RSV infections have become more prevalent. Consequently, a new vaccine targeting RSV infections in pregnant women has been introduced …

jp (code pays fourni par la source)

Analysis of Cell Immunity for Children Infected with SARS-CoV-2 and Those Vaccinated against SARS-CoV-2 Using T-SPOT®.COVID

Tomohiro Oishi, Yuto Yasui, Atsushi Kato, Satoko Ogita et autres

Cellular immunity is critical for the regulation of viral diseases, including coronavirus disease 2019 (COVID-19), and is generally considered immature in childhood. However, the details of cellular immunity against severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection among children are unclear. We …

jp (code pays fourni par la source)

Analysis of Cell Immunity for Children Infected with COVID-19 and Those Vaccinated against COVID-19 Using T-SPOT®.COVID

Tomohiro Oishi, Yuto Yasui, Atsushi Kato, Satoko Ogita et autres

To elucidate the cellular immune response to coronavirus disease (COVID-19) among children, we assessed cellular immunity in 8 children post-vaccination for COVID-19 and 11 children after severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection, using the T-SPOT®.COVID assay for both the spike …

jp (code pays fourni par la source)

Recent acute reduction in macrolide-resistant Mycoplasma pneumoniae infections among Japanese children.

祥崇 中村, Yoshitaka Nakamura, Tomohiro Oishi, Kazunari Kaneko et autres

Mycoplasma pneumoniae contributes to numerous pneumonia cases among children and young adults. Therefore, this study aimed to investigate the prevalence of M.pneumoniae infections among Japanese children, occurring since 2008.

Recent acute reduction in macrolide-resistant Mycoplasma pneumoniae infections among Japanese children

Yoshitaka Nakamura, Tomohiro Oishi, Kazunari Kaneko, Tsuyoshi Kenri et autres

INTRODUCTION: Mycoplasma pneumoniae contributes to numerous pneumonia cases among children and young adults. Therefore, this study aimed to investigate the prevalence of M. pneumoniae infections among Japanese children, occurring since 2008. METHODS: Nasopharyngeal swab specimens were obtained from all cases, following which …

jp (code pays fourni par la source)

Low prevalence of Chlamydia pneumoniae infections during the Mycoplasma pneumoniae epidemic season: Results of nationwide surveillance in Japan

Tomohiro Oishi, Y. Fukuda, Shoko Wakabayashi, Mina Kono et autres

OBJECTIVE: Chlamydia pneumoniae and Mycoplasma pneumoniae are both common causes of atypical pneumonia. We conducted an annual national survey of Japanese children to screen them for C. pneumoniae infections during the M. pneumoniae epidemic season. METHODS: Nasopharyngeal swab specimens were collected from …

jp (code pays fourni par la source)

Reactive oxygen metabolites as a biomarker of congenital heart disease in children

Naoki OHNO, Eisuke Kondo, Hiroto AKAIKE, Ippei Miyata et autres

Comparing Antimicrobial Susceptibilities among Mycoplasma pneumoniae Isolates from Pediatric Patients in Japan between Two Recent Epidemic Periods

Tomohiro Oishi, Kento Takahashi, Shoko Wakabayashi, Yoshitaka Nakamura et autres

We compared the antimicrobial susceptibility of Mycoplasma pneumoniae isolates from pediatric patients in Japan in 2011–2012 and 2015–2016, when epidemics occurred. The antimicrobial activity of macrolides and tetracyclines against M. pneumoniae infection tended to be restored in 2015–2016.

jp (code pays fourni par la source)

Efficacy of primary treatment with immunoglobulin plus ciclosporin for prevention of coronary artery abnormalities in patients with Kawasaki disease predicted to be at increased risk of non-response to intravenous immunoglobulin (KAICA): a randomised controlled, open-label, blinded-endpoints, phase 3 trial

Hiroyuki Suzuki, Masaru Terai, Shigeto Fuse, Yoshitomo Okajima et autres

jp (code pays fourni par la source)

2つの最近の流行期間の日本の小児患者からのMycoplasma pneumoniae分離株間の抗菌薬感受性の比較【JST・京大機械翻訳】

Oishi Tomohiro, Kento Takahashi, Shoko Wakabayashi, Nakamura Yoshitaka et autres

Macrolide-Resistant Mycoplasma pneumoniae Infection, Japan, 2008–2015

Takaaki Tanaka, Tomohiro Oishi, Ippei Miyata, Shoko Wakabayashi et autres

We evaluated isolates obtained from children with Mycoplasma pneumoniae infection throughout Japan during 2008-2015. The highest prevalence of macrolide-resistant M. pneumoniae was 81.6% in 2012, followed by 59.3% in 2014 and 43.6% in 2015. The prevalence of macrolide-resistant M. pneumoniae among children …

jp (code pays fourni par la source)